{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:39:07Z","timestamp":1785213547418,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1001900"],"award-info":[{"award-number":["2017YFC1001900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1001904"],"award-info":[{"award-number":["2017YFC1001904"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Science and Technology Program","doi-asserted-by":"publisher","award":["16YFZCSY00900"],"award-info":[{"award-number":["16YFZCSY00900"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501386"],"award-info":[{"award-number":["81501386"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.bone.2023.116706","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T23:56:12Z","timestamp":1677023772000},"page":"116706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["DNA methyltransferases inhibitor azacitidine improves the skeletal phenotype of mild osteogenesis imperfecta by reversing the impaired osteogenesis and excessive osteoclastogenesis"],"prefix":"10.1016","volume":"170","author":[{"given":"Chenyi","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaci","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bone.2023.116706_bb0005","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MED.0000000000000367","article-title":"Osteogenesis imperfecta: diagnosis and treatment [J]","volume":"24","author":"Palomo","year":"2017","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"1","key":"10.1016\/j.bone.2023.116706_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1302\/1863-2548.13.180190","article-title":"Current concepts in osteogenesis imperfecta: bone structure, biomechanics and medical management [J]","volume":"13","author":"Nijhuis","year":"2019","journal-title":"J. Child. Orthop."},{"issue":"1","key":"10.1016\/j.bone.2023.116706_bb0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/MOP.0000000000000968","article-title":"Osteogenesis imperfecta: treatment and surgical management [J]","volume":"33","author":"Hidalgo Perea","year":"2021","journal-title":"Curr. Opin. Pediatr."},{"issue":"1","key":"10.1016\/j.bone.2023.116706_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a Task Force of the American Society for Bone and Mineral Research [J]","volume":"31","author":"Adler","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2023.116706_bb0025","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152571","article-title":"Targeting TGF-beta for treatment of osteogenesis imperfecta [J]","volume":"132","author":"Song","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2023.116706_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","article-title":"Disorders of bone remodeling [J]","volume":"6","author":"Feng","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bone.2023.116706_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2021.03.001","article-title":"Targeting cellular stress in vitro improves osteoblast homeostasis, matrix collagen content and mineralization in two murine models of osteogenesis imperfecta [J]","volume":"98","author":"Garibaldi","year":"2021","journal-title":"Matrix Biol."},{"issue":"7","key":"10.1016\/j.bone.2023.116706_bb0040","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/stem.1107","article-title":"Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy [J]","volume":"30","author":"Gioia","year":"2012","journal-title":"Stem Cells"},{"issue":"6","key":"10.1016\/j.bone.2023.116706_bb0045","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1074\/jbc.TM118.002812","article-title":"Roles of the endoplasmic reticulum-resident, collagen-specific molecular chaperone Hsp47 in vertebrate cells and human disease [J]","volume":"294","author":"Ito","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bone.2023.116706_bb0050","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/jbmr.2824","article-title":"Osteoblast malfunction caused by cell stress response to procollagen misfolding in alpha2(I)-G610C mouse model of osteogenesis imperfecta [J]","volume":"31","author":"Mirigian","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"5 Pt A","key":"10.1016\/j.bone.2023.116706_bb0055","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.bbadis.2018.02.002","article-title":"4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion [J]","volume":"1864","author":"Besio","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bone.2023.116706_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2017.06.004","article-title":"Splenomegaly, myeloid lineage expansion and increased osteoclastogenesis in osteogenesis imperfecta murine [J]","volume":"103","author":"Matthews","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bone.2023.116706_bb0065","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bone.2019.07.021","article-title":"A novel transgenic murine model with persistently brittle bones simulating osteogenesis imperfecta type I [J]","volume":"127","author":"Liu","year":"2019","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.bone.2023.116706_bb0070","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1359\/jbmr.080804","article-title":"Cellular mechanism of decreased bone in brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors [J]","volume":"23","author":"Uveges","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2023.116706_bb0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s007740200025","article-title":"Increased bone resorption with decreased activity and increased recruitment of osteoblasts in osteogenesis imperfecta type I [J]","volume":"20","author":"Iwamoto","year":"2002","journal-title":"J. Bone Miner. Metab."},{"issue":"4","key":"10.1016\/j.bone.2023.116706_bb0080","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1359\/jbmr.081225","article-title":"Large osteoclasts in pediatric osteogenesis imperfecta patients receiving intravenous pamidronate [J]","volume":"24","author":"Cheung","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2023.116706_bb0085","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11914-017-0391-y","article-title":"Epigenetics and bone remodeling [J]","volume":"15","author":"Husain","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"issue":"353","key":"10.1016\/j.bone.2023.116706_bb0090","doi-asserted-by":"crossref","first-page":"353ra113","DOI":"10.1126\/scitranslmed.aad8949","article-title":"Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma [J]","volume":"8","author":"Liu","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.bone.2023.116706_bb0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.3774","article-title":"DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway [J]","volume":"21","author":"Nishikawa","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2023.116706_bb0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bone.2018.03.017","article-title":"Overexpression of DNMT1 leads to hypermethylation of H19 promoter and inhibition of erk signaling pathway in disuse osteoporosis [J]","volume":"111","author":"Li","year":"2018","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2023.116706_bb0105","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41467-020-20715-x","article-title":"Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease [J]","volume":"12","author":"Garcia-Gomez","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bone.2023.116706_bb0110","doi-asserted-by":"crossref","DOI":"10.1007\/s12038-019-9901-7","article-title":"5-azacytidine and trichostatin a enhance the osteogenic differentiation of bone marrow mesenchymal stem cells isolated from steroid-induced avascular necrosis of the femoral head in rabbit [J]","volume":"44","author":"Zhang","year":"2019","journal-title":"J. Biosci."},{"issue":"5","key":"10.1016\/j.bone.2023.116706_bb0115","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1073\/pnas.90.5.1701","article-title":"Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta [J]","volume":"90","author":"Chipman","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bone.2023.116706_bb0120","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s10439-013-0793-7","article-title":"Gender-dependence of bone structure and properties in adult osteogenesis imperfecta murine model [J]","volume":"41","author":"Yao","year":"2013","journal-title":"Ann. Biomed. Eng."},{"issue":"8","key":"10.1016\/j.bone.2023.116706_bb0125","first-page":"8544","article-title":"Leptin inhibits AMPKalpha2 down-regulation induced decrease in the osteocytic MLO-Y4 cell proliferation and the expression of osteogenic markers [J]","volume":"10","author":"Fan","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.bone.2023.116706_bb0130","first-page":"490","article-title":"Construction of lentivirus vector carrying HGF and exploration of transfection condition of rat adipocyte-derived mesenchymal stem Cells] [J","volume":"23","author":"Zhang","year":"2015","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"2","key":"10.1016\/j.bone.2023.116706_bb0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jmv.1890350203","article-title":"Persistence of cytomegalovirus in human long-term bone marrow culture: relationship to hemopoiesis [J]","volume":"35","author":"Preiksaitis","year":"1991","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.bone.2023.116706_bb0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.cgt.7701105","article-title":"A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes [J]","volume":"15","author":"Hu","year":"2008","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bone.2023.116706_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110235","article-title":"The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment [J]","volume":"128","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.bone.2023.116706_bb0150","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bpj.2011.11.3999","article-title":"Structural and mechanical differences between collagen homo- and heterotrimers: relevance for the molecular origin of brittle bone disease [J]","volume":"102","author":"Chang","year":"2012","journal-title":"Biophys. J."},{"issue":"6","key":"10.1016\/j.bone.2023.116706_bb0155","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.bone.2005.03.004","article-title":"Dental phenotype of the col1a2(oim) mutation: DI is present in both homozygotes and heterozygotes [J]","volume":"36","author":"Lopez Franco","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2023.116706_bb0160","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/bonekey.2016.60","article-title":"Post-yield and failure properties of cortical bone [J]","volume":"5","author":"Wolfram","year":"2016","journal-title":"Bonekey Rep."},{"issue":"6","key":"10.1016\/j.bone.2023.116706_bb0165","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S8756-3282(96)00305-5","article-title":"Heterozygous oim mice exhibit a mild form of osteogenesis imperfecta [J]","volume":"19","author":"Saban","year":"1996","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.bone.2023.116706_bb0170","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s00198-016-3501-2","article-title":"Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-alpha [J]","volume":"27","author":"Brunetti","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2023.116706_bb0175","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2016.14322","article-title":"Osteogenesis imperfecta: from diagnosis and multidisciplinary treatment to future perspectives [J]","volume":"146","author":"Bregou Bourgeois","year":"2016","journal-title":"Swiss Med. Wkly."},{"issue":"5","key":"10.1016\/j.bone.2023.116706_bb0180","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.encep.2014.06.005","article-title":"Epigenetics of schizophrenia: a review] [J","volume":"40","author":"Rivollier","year":"2014","journal-title":"Enc\u00e9phale"},{"issue":"9","key":"10.1016\/j.bone.2023.116706_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17091446","article-title":"Epigenetic regulation of bone remodeling and its impacts in osteoporosis [J]","volume":"17","author":"Ghayor","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bone.2023.116706_bb0190","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biocel.2014.03.025","article-title":"Bone defects: molecular and cellular therapeutic targets [J]","volume":"51","author":"Desiderio","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.bone.2023.116706_bb0195","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41431-019-0387-4","article-title":"Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat osteogenesis imperfecta [J]","volume":"27","author":"Hill","year":"2019","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bone.2023.116706_bb0200","doi-asserted-by":"crossref","first-page":"4824209","DOI":"10.1155\/2019\/4824209","article-title":"Dnmt3a-mediated DNA methylation changes regulate osteogenic differentiation of hMSCs cultivated in the 3D scaffolds under oxidative stress [J]","volume":"2019","author":"Li","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.bone.2023.116706_bb0205","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/jbmr.4501","article-title":"4-PBA treatment improves bone phenotypes in the Aga2 mouse model of osteogenesis imperfecta [J]","volume":"37","author":"Duran","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.bone.2023.116706_bb0210","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00439-021-02302-2","article-title":"Collagen transport and related pathways in osteogenesis imperfecta [J]","volume":"140","author":"Claeys","year":"2021","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bone.2023.116706_bb0215","doi-asserted-by":"crossref","first-page":"1523140","DOI":"10.1155\/2019\/1523140","article-title":"5-azacytidine and resveratrol enhance chondrogenic differentiation of metabolic syndrome-derived mesenchymal stem cells by modulating autophagy [J]","volume":"2019","author":"Marycz","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bone.2023.116706_bb0220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/jcmm.13914","article-title":"5-azacytydine and resveratrol reverse senescence and ageing of adipose stem cells via modulation of mitochondrial dynamics and autophagy [J]","volume":"23","author":"Kornicka","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.bone.2023.116706_bb0225","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4049\/jimmunol.2100624","article-title":"DNMT1 deficiency impacts on plasmacytoid dendritic cells in homeostasis and autoimmune disease [J]","volume":"208","author":"Czeh","year":"2022","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.bone.2023.116706_bb0230","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.bbagrm.2016.09.007","article-title":"Distinct and overlapping DNMT1 interactions with multiple transcription factors in erythroid cells: evidence for co-repressor functions [J]","volume":"1859","author":"Papageorgiou","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bone.2023.116706_bb0235","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030320","article-title":"DNMT3A in Leukemia [J]","volume":"7","author":"Brunetti","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"10","key":"10.1016\/j.bone.2023.116706_bb0240","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1172\/JCI93041","article-title":"Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies [J]","volume":"127","author":"Cole","year":"2017","journal-title":"J. Clin. Invest."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328223000388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328223000388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:05:05Z","timestamp":1757613905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328223000388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":48,"alternative-id":["S8756328223000388"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2023.116706","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA methyltransferases inhibitor azacitidine improves the skeletal phenotype of mild osteogenesis imperfecta by reversing the impaired osteogenesis and excessive osteoclastogenesis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2023.116706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116706"}}